El delito de feminicidio durante el estado de emergencia sanitaria por la COVID –19

En esta tesis titulada “El delito de feminicidio durante el estado de emergencia sanitaria por la COVID-19” donde tuvo como objetivo principal: Determinar los factores que generan el incremento del delito de feminicidio durante el estado de emergencia por la COVID-19. La metodología empleada fue de un enfoque cualitativa de tipo básica con un diseño de investigación fenomenológico, con sus respectivos instrumentos la guía de entrevista y la guía de análisis documental, A partir de los datos obtenidos y suanálisis respectivo, para conseguir los objetivos planteados se contó con la participación de 5 especialistas en el tema, entre ellos fiscal, psicólogos, abogado y criminólogo quienes en su mayoría estuvieron de acuerdo que durante la pandemia hubo un incremento del delito de feminicidio. Finalmente se concluyó, los factores que generaron el incremento del delito de feminicidio fueron el factor emocional y económico y que durante el aislamiento social por la covid-19, jugaron un papel fundamental para que se consuma el feminicidio

Efecto de la formación como monitores comunitarios en la autoeficacia y autoestima de un grupo de adultos mayores de CES La Florida de Talca

66 p.La presente memoria contempla la realización de un estudio de caso de un grupo de adultos mayores, los cuales han participado de un programa de formación como monitores, para trabajar con personas con discapacidad visual adquirida dentro de su comunidad, la cual corresponde al sector La Florida de la ciudad de Talca, durante el año 2009, pues se ha descrito en la literatura que, conceptos como autoeficacia y autoestima están íntimamente relacionados con las conductas en salud, influyendo en la funcionalidad y, en consecuencia, en la calidad de vida de las personas. Los sujetos en estudio serán sometidos a una evaluación mediante la aplicación de dos escalas para medir el nivel de autoeficacia y de autoestima percibida. Ambas escalas, validadas, serán aplicadas en dos instancias: al comienzo del programa de formación y luego de 6 meses de la intervención en su propia comunidad a través del CES La Florida de Talca. A partir de esta evaluación se pretende analizar si existen cambios en los niveles de autoeficacia y autoestima percibida y se discutirá su implicancia en las conductas en salud de los participantes. Además, se pretende discutir el rol del Kinesiólogo en el modelo de Rehabilitación Comunitaria, según las nuevas Políticas de Salud Familiar orientadas al proceso de envejecimiento, con el fin de establecer este tipo de trabajo como estrategia de seguimiento en la mantención de la salud y capacidades funcionales de la población adulta mayor y su influencia en la comunidad

El enfoque cognitivo en el tratamiento de una adolescente con obsesiones y compulsiones de contenido sexual

El presente trabajo es un estudio de caso único sobre una adolescente de 15 años con un trastorno obsesivo compulsivo (TOC) de contenido sexual. Este tipo de obsesiones y compulsiones tienen la particularidad de la ocultación, ya que aquellos que lo padecen acostumbran a esconder los síntomas por ser percibidos como inaceptables. El tratamiento utilizado combina técnicas cognitivas en los momentos iniciales y técnicas conductuales (exposición con prevención de respuesta, EPR). Se llevó a cabo una evaluación pretest-postest empleando la Child Behavior Checklist (CBCL), la Youth Self-Report (YSR) y la Children’s Yale-Brown Obsessive Compulsive Scale (CY-BOCS). La evolución fue favorable, observándose una reducción notable en las obsesiones y compulsiones tras la aplicación de las técnicas cognitivas y obteniendo una remisión completa aplicando de forma consecutiva la exposición con prevención de respuesta. Este estudio subraya la importancia de un modelo de intervención cognitivo en la intervención del TOC en adolescentes con obsesiones de tipo sexual, además de la técnica de EPR

DNA copy number variation associated with anti-tumour necrosis factor drug response and paradoxical psoriasiform reactions in patients with moderate-to-severe psoriasis

Biological drugs targeting tumour necrosis factor are effective for psoriasis. However, 30–50% of patients do not respond to these drugs and may even develop paradoxical psoriasiform reactions. This study search-ed for DNA copy number variations that could predict anti-tumour necrotic factor drug response or the ap-pearance of anti-tumour necrotic factor induced pso-riasiform reactions. Peripheral blood samples were collected from 70 patients with anti-tumour necrotic factor drug-treated moderate-to-severe plaque pso-riasis. Samples were analysed with an Illumina 450K methylation microarray. Copy number variations were obtained from raw methylation data using conumee and Chip Analysis Methylation Pipeline (ChAMP) R packa-ges. One copy number variation was found, harbouring one gene (CPM) that was significantly associated with adalimumab response (Bonferroni-adjusted p-value < 0.05). Moreover, one copy number variation was identified harbouring 3 genes (ARNT2, LOC101929586 and MIR5572) related to the development of paradoxical psoriasiform reactions. In conclusion, this study has identified DNA copy number variations that could be good candidate markers to predict response to ada-limumab and the development of anti-tumour necrotic factor paradoxical psoriasiform reactions.This study was supported by Instituto de Salud Carlos III PI 13/01598 and the Ministry of Science and Innovation and the European Regional Development’s funds (FEDER). Conflicts of interest. FA-S has been a consultant or investigator in clinical trials sponsored by the following pharmaceutical companies: Abbott, Alter, Chemo, Farmalíder, Ferrer, GlaxoSmithKline, Gilead, Janssen-Cilag, Kern, Normon, Novartis, Servier, Teva, and Zambon. ED has potential conflicts of interest (advisory board member, consultant, grants, research support, participation in clinical trials, honoraria for speaking, and research support) with the following pharmaceutical companies: AbbVie (Abbott), Amgen, Janssen-Cilag, Leo Pharma, Novartis, Pfizer, MSD, Lilly and Celgene. ML-V has potential conflicts of interest as she has participated in clinical trials or as consultant with Abbvie (Abbott), Galderma, Janssen-Cilag, Leo Pharma, Pfizer, Novarties, Lilly, Almirall and Celgene. MCO-B has potential conflicts of interest (honoraria for speaking and research support) with Janssen-Cilag and Leo Pharma. The other authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. AS-T has served as a consultant and/or paid speaker for and/or participated in clinical trials sponsored by companies that manufacture drugs used for the treatment of psoriasis, including AbbVie, Celgene, Janssen-Cilag, LEO Pharma, Lilly, Novartis and Pfizer. RB-E has served as a consultant and/or paid speaker for and/or participated in clinical trials sponsored by companies that manufacture drugs used for the treatment of psoriasis, including AbbVie, Celgene, Janssen-Cilag, LEO Pharma, Lilly, Novartis and Pfizer

Els treballs de fi de grau a la Universitat de Barcelona

Podeu consultar la versió castellana al camp recurs relacionat.La implantació dels títols de grau ha suposat un repte per a les universitats, que han hagut d'adaptar els seus projectes formatius a les directrius de l’Espai Europeu d’Educació Superior. Un dels aspectes importants d’aquest procés ha estat l'obligació d’incorporar els treballs de fi de grau (TFG) a l’estructura curricular dels plans d’estudis. Aquesta tasca ha estat complexa i, a més, s’ha vist dificultada per la poca tradició que la majoria de facultats i escoles universitàries tenien en el disseny, l'organització i l'avaluació d’aquest tipus de treball. Uns quants cursos després d’haver-se posat en marxa els TFG, l’Institut de Ciències de l’Educació (ICE) de la Universitat de Barcelona va voler oferir als diferents centres de la UB una plataforma de reflexió i debat on poguessin compartir experiències, plantejar dubtes, analitzar models de bones pràctiques i recollir idees per millorar els seus projectes. A tal efecte, des de la Secció d’Universitat de l’ICE, es va organitzar la jornada «Els treballs de fi de grau a la UB». Aquest quadern recull les comunicacions presentades, sintetitza el debat que van generar i presenta les conclusions a què es va arribar

Predictors of clinically significant quality of life impairment in Parkinson’s disease

COPPADIS Study Group.Quality of life (QOL) plays an important role in independent living in Parkinson’s disease (PD) patients, being crucial to know what factors impact QoL throughout the course of the disease. Here we identified predictors of QoL impairment in PD patients from a Spanish cohort. PD patients recruited from 35 centers of Spain from the COPPADIS cohort from January 2016, to November 2017, were followed up during 2 years. Health-related QoL (HRQoL) and global QoL (GQoL) were assessed with the 39-item Parkinson’s disease Questionnaire (PDQ-39) and the EUROHIS-QOL 8-item index (EUROHIS-QOL8), respectively, at baseline (V0) and at 24 months ± 1 month (V2). Clinically significant QoL impairment was defined as presenting an increase (PDQ-39SI) or decrement (EUROHIS-QOL8) at V2 ≥ 10% of the score at baseline (V0). A comparison with a control group was conducted for GQoL. GQoL did not change significantly in PD patients (N = 507; p = 0.686) or in the control group (N = 119; p = 0.192). The mean PDQ-39SI was significantly increased in PD patients (62.7 ± 8.5 years old; 58.8% males; N = 500) by 21.6% (from 16.7 ± 13 to 20.3 ± 16.4; p < 0.0001) at V2. Ninety-three patients (18.6%) presented a clinically significant HRQoL impairment at V2. To be younger (OR = 0.896; 95% CI 0.829–0.968; p = 0.006), to be a female (OR = 4.181; 95% CI 1.422–12.290; p = 0.009), and to have a greater increase in BDI-II (Beck Depression Inventory-II) (OR = 1.139; 95% CI 1.053–1.231; p = 0.001) and NMSS (Non-Motor Symptoms Scale) (OR = 1.052; 95% CI 1.027–1.113; p < 0.0001) total scores from V0 to V2 were associated with clinically significant HRQoL impairment at the 2-year follow-up (Hosmer–Lemeshow test, p = 0.665; R 2 = 0.655). An increase in ≥5 and ≥10 points of BDI-II and NMSS total score at V2 multiplied the probability of presenting clinically significant HRQoL impairment by 5 (OR = 5.453; 95% CI 1.663–17.876; p = 0.005) and 8 (OR = 8.217; 95% CI, 2.975–22.696; p = 0.002), respectively. In conclusion, age, gender, mood, and non-motor impairment were associated with clinically significant HRQoL impairment after the 2-year follow-up in PD patients.Mir P. has received honoraria from AbbVie, Abbott, Allergan, Bial, Merz, UCB and Zambon and have received grants from the Spanish Ministry of Economy and Competitiveness [PI16/01575] co-founded by ISCIII (Subdirección General de Evaluación y Fomento de la Investigación) and by Fondo Europeo de Desarrollo Regional (FEDER), the Consejería de Economía, Innovación, Ciencia y Empleo de la Junta de Andalucía [CVI-02526, CTS-7685], the Consejería de Salud y Bienestar Social de la Junta de Andalucía [PI-0437-2012, PI-0471-2013], the Sociedad Andaluza de Neurología, the Jacques and Gloria Gossweiler Foundation, the Fundación Alicia Koplowitz, the Fundación Mutua Madrileña.Peer reviewe

Predictors of Global Non-Motor Symptoms Burden Progression in Parkinson’s Disease. Results from the COPPADIS Cohort at 2-Year Follow-Up

COPPADIS Study Group.[Background and Objective] Non-motor symptoms (NMS) progress in different ways between Parkinson’s disease (PD) patients. The aim of the present study was to (1) analyze the change in global NMS burden in a PD cohort after a 2-year follow-up, (2) to compare the changes with a control group, and (3) to identify predictors of global NMS burden progression in the PD group.[Material and Methods] PD patients and controls, recruited from 35 centers of Spain from the COPPADIS cohort from January 2016 to November 2017, were followed-up with after 2 years. The Non-Motor Symptoms Scale (NMSS) was administered at baseline (V0) and at 24 months ± 1 month (V2). Linear regression models were used for determining predictive factors of global NMS burden progression (NMSS total score change from V0 to V2 as dependent variable).[Results] After the 2-year follow-up, the mean NMS burden (NMSS total score) significantly increased in PD patients by 18.8% (from 45.08 ± 37.62 to 53.55 ± 42.28; p < 0.0001; N = 501; 60.2% males, mean age 62.59 ± 8.91) compared to no change observed in controls (from 14.74 ± 18.72 to 14.65 ± 21.82; p = 0.428; N = 122; 49.5% males, mean age 60.99 ± 8.32) (p < 0.0001). NMSS total score at baseline (β = −0.52), change from V0 to V2 in PDSS (Parkinson’s Disease Sleep Scale) (β = −0.34), and change from V0 to V2 in NPI (Neuropsychiatric Inventory) (β = 0.25) provided the highest contributions to the model (adjusted R-squared 0.41; Durbin-Watson test = 1.865).[Conclusions] Global NMS burden demonstrates short-term progression in PD patients but not in controls and identifies worsening sleep problems and neuropsychiatric symptoms as significant independent predictors of this NMS progression.This research was funded by Fundación Española de Ayuda a la Investigación en Parkinson y otras Enfermedades Neuro-degenerativas (Curemos el Parkinson; www.curemoselparkinson.org).Peer reviewe

Staging Parkinson’s Disease Combining Motor and Nonmotor Symptoms Correlates with Disability and Quality of Life

COPPADIS Study Group.[Introduction] In a degenerative disorder such as Parkinson’s disease (PD), it is important to establish clinical stages that allow to know the course of the disease. Our aim was to analyze whether a scale combining Hoehn and Yahr’s motor stage (H&Y) and the nonmotor symptoms burden (NMSB) (assessed by the nonmotor symptoms scale (NMSS)) provides information about the disability and the patient’s quality of life (QoL) with regard to a defined clinical stage.[Materials and Methods] Cross-sectional study in which 603 PD patients from the COPPADIS cohort were classified according to H&Y (1, stage I; 2, stage II; 3, stage III; 4, stage IV/V) and NMSB (A: NMSS = 0–20; B: NMSS = 21–40; C: NMSS = 41–70; D: NMSS ≥ 71) in 16 stages (HY.NMSB, from 1A to 4D). QoL was assessed with the PDQ-39SI, PQ-10, and EUROHIS-QOL8 and disability with the Schwab&England ADL (Activities of Daily Living) scale.[Results] A worse QoL and greater disability were observed at a higher stage of H&Y and NMSB (). Combining both (HY.NMSB), patients in stages 1C and 1D and 2C and 2D had significantly worse QoL and/or less autonomy for ADL than those in stages 2A and 2B and 3A and 3B, respectively (; e.g., PDQ-39SI in 1D [n = 15] vs 2A [n = 101]: 28.6 ± 17.1 vs 7.9 ± 5.8; ).[Conclusion] The HY.NMSB scale is simple and reflects the degree of patient involvement more accurately than the H&Y. Patients with a lower H&Y stage may be more affected if they have a greater NMS burden.Peer reviewe

Staging Parkinson's Disease Combining Motor and Nonmotor Symptoms Correlates with Disability and Quality of Life.

Introduction: In a degenerative disorder such as Parkinson's disease (PD), it is important to establish clinical stages that allow to know the course of the disease. Our aim was to analyze whether a scale combining Hoehn and Yahr's motor stage (H&Y) and the nonmotor symptoms burden (NMSB) (assessed by the nonmotor symptoms scale (NMSS)) provides information about the disability and the patient's quality of life (QoL) with regard to a defined clinical stage. Materials and methods: Cross-sectional study in which 603 PD patients from the COPPADIS cohort were classified according to H&Y (1, stage I; 2, stage II; 3, stage III; 4, stage IV/V) and NMSB (A: NMSS = 0-20; B: NMSS = 21-40; C: NMSS = 41-70; D: NMSS ≥ 71) in 16 stages (HY.NMSB, from 1A to 4D). QoL was assessed with the PDQ-39SI, PQ-10, and EUROHIS-QOL8 and disability with the Schwab&England ADL (Activities of Daily Living) scale. Results: A worse QoL and greater disability were observed at a higher stage of H&Y and NMSB (p < 0.0001). Combining both (HY.NMSB), patients in stages 1C and 1D and 2C and 2D had significantly worse QoL and/or less autonomy for ADL than those in stages 2A and 2B and 3A and 3B, respectively (p < 0.005; e.g., PDQ-39SI in 1D [n = 15] vs 2A [n = 101]: 28.6 ± 17.1 vs 7.9 ± 5.8; p < 0.0001). Conclusion: The HY.NMSB scale is simple and reflects the degree of patient involvement more accurately than the HΨ Patients with a lower H&Y stage may be more affected if they have a greater NMS burden

Los trabajos de fin de grado en la Universidad de Barcelona

Podeu consultar la versió catalana al camp recurs relacionat.[spa] La implantación de los títulos de grado ha supuesto un reto para las universidades, que han tenido que adaptar sus proyectos formativos a las directrices del Espacio Europeo de Educación Superior. Uno de los aspectos importantes de este proceso ha sido la obligación de incorporar los trabajos de fin de grado (TFG) a la estructura curricular de los planes de estudios. Esta tarea ha sido compleja y, además, se ha visto dificultada por la poca tradición que la mayoría de facultades y escuelas universitarias tenían en el diseño, organización y evaluación de esta clase de trabajo. Después de varios cursos de haberse puesto en marcha los TFG, el Instituto de Ciencias de la Educación (ICE) de la Universidad de Barcelona quiso ofrecer a los diferentes centros de la UB una plataforma de reflexión y debate donde pudieran compartir experiencias, plantear dudas, analizar modelos de buenas prácticas y recoger ideas para mejorar sus proyectos. A tal efecto, desde la Sección de Universidad del ICE se organizó la jornada «Los trabajos de fin de grado en la UB». Este cuaderno recoge las comunicaciones presentadas, sintetiza el debate que generaron y presenta las conclusiones a que se llegó.[eng] The phase-in of undergraduate degrees conforming to the guidelines of the European Higher Education Area has been a challenge for universities as far as their training projects are concerned. An important aspect of this process was the need to incorporate the Bachelor’s Degree Final Project (TFG) to the structure of their curricula. This task has been complex and been hampered also by the lack of tradition that most faculties and university colleges had in the design, organization and evaluation of these types of project. Several years after launching the TFG, the Institute of Education Sciences (ICE) of the University of Barcelona (UB) organized the «The Bachelor’s Degree Final Project» conference to offer different centres of the UB a space for reflection and debate to be able to share experiences, ask questions, analyse models of good practices and gather ideas for improving their projects. The present booklet includes papers, summarizes the debate that many and varied contributions generated and outlines the final conclusions reached at this conference